Program

85
10
4
1

Journal Year Published

8
3
10
9
18
6
12
7
11
5
3
3

Author

95
201
181
149
139
133
133
125
123
108
105
82
78
63
62
54
50
46
43
43

Category

60
19
19
15
7
2
1
1

Keyword

37
23
16
15
14
12
12
10
7
7
6
6
6
6
5
5
5
5
5
5

Journal

9
7
4
4
4
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2

NCATS Publications

Repurposing of the antihistamine chlorcyclizine and related compounds for treatment of hepatitis C virus infection.


He S, Lin B, Chu V, Hu Z, Hu X, Xiao J, Wang A, Schweitzer CJ, Li Q, Imamura M, Hiraga N, Southall N, Ferrer-Alegre M, Zheng W, Chayama K, Marugan J, Liang TJ


Sci Transl Med , (7), 282ra49, 2015.

Article Pubmed

Sample image from publication page

Up-regulation of lysosomal TRPML1 channels is essential for lysosomal adaptation to nutrient starvation.


Wang W, Gao Q, Yang M, Zhang X, Yu L, Lawas M, Li X, Bryant-Genevier M, Southall N, Marugan J, Ferrer-Alegre M, Xu H


Proc. Natl. Acad. Sci. U.S.A. , (112), E1373-81, 2015.

Article Pubmed

Sample image from publication page

Targeting ATM ameliorates mutant Huntingtin toxicity in cell and animal models of Huntington's disease.


Lu X, Mattis VB, Wang N, Al-Ramahi I, van den Berg N, Fratantoni SA, Waldvogel H, Greiner E, Osmand A, Elzein K, Xiao J, Dijkstra S, de Pril R, Vinters HV, Faull R, Signer E, Kwak S, Marugan J, Botas J, Fischer DF, Svendsen CN, Munoz-Sanjuan I, Yang XW


Sci Transl Med , (6), 268ra178, 2014.

Article Pubmed

Sample image from publication page

Discovery of novel antigiardiasis drug candidates.


Kulakova L, Galkin A, Chen C, Southall N, Marugan J, Zheng W, Herzberg O


Antimicrob. Agents Chemother. , (58), 7303-11, 2014.

Article Pubmed

Sample image from publication page

Macrophage models of Gaucher disease for evaluating disease pathogenesis and candidate drugs.


Aflaki E, Stubblefield BK, Maniwang E, Lopez G, Moaven N, Goldin E, Marugan J, Patnaik S, Dutra A, Southall N, Zheng W, Tayebi N, Sidransky E


Sci Transl Med , (6), 240ra73, 2014.

Article Pubmed

Sample image from publication page

Niemann-Pick Disease Type C: Induced Pluripotent Stem Cell-Derived Neuronal Cells for Modeling Neural Disease and Evaluating Drug Efficacy.


Yu D, Swaroop M, Wang M, Baxa U, Yang R, Yan Y, Coksaygan T, DeTolla L, Marugan J, Austin C, McKew JC, Gong DW, Zheng W


J Biomol Screen , (19), 1164-73, 2014.

Article Pubmed

Sample image from publication page

A multiplex high-throughput gene expression assay to simultaneously detect disease and functional markers in induced pluripotent stem cell-derived retinal pigment epithelium.


Ferrer-Alegre M, Corneo B, Davis J, Wan Q, Miyagishima KJ, King R, Maminishkis A, Marugan J, Sharma R, Shure M, Temple S, Miller S, Bharti K


Stem Cells Transl Med , (3), 911-22, 2014.

Article Pubmed

Sample image from publication page

Lomofungin and dilomofungin: inhibitors of MBNL1-CUG RNA binding with distinct cellular effects.


Hoskins JW, Ofori LO, Chen C, Kumar A, Sobczak K, Nakamori M, Southall N, Patnaik S, Marugan J, Zheng W, Austin C, Disney MD, Miller BL, Thornton CA


Nucleic Acids Res. , (42), 6591-602, 2014.

Article Pubmed

Sample image from publication page